These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2962735)

  • 21. Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor.
    Varesio L; Giovarelli M; Landolfo S; Forni G
    Cancer Res; 1979 Dec; 39(12):4983-8. PubMed ID: 159126
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
    Vujanovic NL; Herberman RB; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL; Boyer CM; Purnell DM
    Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
    Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat.
    Quan N; Zhang Z; Demetrikopoulos MK; Kitson RP; Chambers WH; Goldfarb RH; Weiss JM
    Cancer Res; 1999 Mar; 59(5):1080-9. PubMed ID: 10070966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity in the sensitivities of the 13762NF rat mammary adenocarcinoma cell clones to cytolysis mediated by extra- and intratumoral macrophages.
    North SM; Nicolson GL
    Cancer Res; 1985 Apr; 45(4):1453-8. PubMed ID: 3978611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppression during viral oncogenesis. IV. Generation of soluble virus-induced immunologic suppressor molecules.
    Strayer DS; Korber K; Dombrowski J
    J Immunol; 1988 Mar; 140(6):2051-9. PubMed ID: 2831278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
    [No Abstract]   [Full Text] [Related]  

  • 29. Discrimination of 2 types of suppressor T cells by cell surface phenotype and by function: the ability to regulate the contrasuppressor circuit.
    Green DR; Chue B; Gershon RK
    J Mol Cell Immunol; 1983; 1(1):19-30. PubMed ID: 6242848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.
    Giovarelli M; Musiani P; Modesti A; Dellabona P; Casorati G; Allione A; Consalvo M; Cavallo F; di Pierro F; De Giovanni C
    J Immunol; 1995 Sep; 155(6):3112-23. PubMed ID: 7673726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of T cells involved in the expression of delayed hypersensitivity and tumor rejection immunity to 13762A rat mammary adenocarcinoma.
    Kreider JW; Howell LE; Bartlett GL
    Cell Immunol; 1985 Jun; 93(1):26-37. PubMed ID: 3922632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the expression of adoptive tumor rejection immunity by recipient cyclophosphamide-sensitive cells.
    Boyer CM; Kreider JW; Bartlett GL
    Cancer Res; 1982 Jun; 42(6):2211-5. PubMed ID: 7042079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
    Tsuchiya Y; Igarashi M; Suzuki R; Kumagai K
    J Immunol; 1988 Jul; 141(2):699-708. PubMed ID: 2968407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and initial characterization of concanavalin A- and interferon-induced human suppressor factors: evidence for a human equivalent of murine soluble immune response suppressor (SIRS).
    Schnaper HW; Pierce CW; Aune TM
    J Immunol; 1984 May; 132(5):2429-35. PubMed ID: 6232318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of suppression by a murine nonspecific suppressor-inducer cell line (M1-A5). III. Partial purification of the suppressor cell-inducing factors.
    Almawi WY; Dolphin PJ; Pope BL
    J Mol Cell Immunol; 1987; 3(3):157-66. PubMed ID: 2978241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes.
    Yamamoto H; Hirayama M; Genyea C; Kaplan J
    J Immunol; 1994 Apr; 152(8):3842-7. PubMed ID: 8144953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.